Consolidated financial accounts of JSC Olainfarm for 2010 show that the Company has set yet another record in profits by making the net profit of 3.53 million lats (5.02 million euros). This represents nearly 50% increase compared to the net profit of 2009, when JSC Olainfarm made the net profit of 2.36 million lats (3.36 million euros).
Unaudited profit and loss statement of JSC Olainfarm for 2010 shows that the company made sales of 25.02 million lats (35.61 million euros). Concern’s after tax profit during this period was 3 525 897 lats (5 016 899 euros). In 2009 JSC Olainfarm made net profit of 2 363 063 lats (3 362 336 euros).
“Strategy implemented so far has been the right one. JSC Olainfarm has demonstrated good financial performance. In the near future we do not see any major threats for further growth, so there are reasons to expect that the growth will persist,” says Valerijs Maligins, Chairman of the Board of JSC Olainfarm.
In 2010 AS “Olainfarm” increased sales to all its key markets, except Latvia. Biggest increases were experienced in Moldova (by 118%), Uzbekistan (by 49%), Georgia (by 39%), Ukraine (by 25%), Russia (by 23%), Belarus (by 16%) and Kazakhstan (by 15%).
Annual General Meeting of Shareholders of Olainfarm held on April 29, 2010 approved the operating plan of the company. According to it, the forecast sales of the Concern for 2010 were 24.5 million lats (34.9 million Euro), but the net profit was forecast at 2.7 million lats (3.8 million Euro). According to the unaudited report the sales target has been exceeded by more than 2%, while the profit target was exceeded by nearly 31%.
JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.
Information prepared by:
Member of the Board
Tel: +371 6 7013 717
Cell: +371 2 6448 873